Markgraf, Daniel
Deutsches Diabetes-Zentrum e.V. · German Center for Diabetes Research · Heinrich Heine University Düsseldorf
2 papers on CoChatORCID 0000-0002-2252-8442
Most cited papers
- Verified
Empagliflozin effectively lowers liver fat content in well-controlled type 2 diabetes: a randomized, double-blind, phase 4, placebo-controlled trial
Kahl, S., Gancheva, S., Straßburger, K., Herder, C., Machann, J., Katsuyama, H., Kabisch, S., Henkel, E., Kopf, S., Lagerpusch, M., et al. (2020) · Diabetes Care
Diabetes Treatment and ManagementLiver Disease Diagnosis and Treatment
Cited by 360
- Verified
Specific hepatic sphingolipids relate to insulin resistance, oxidative stress, and inflammation in nonalcoholic steatohepatitis
Apostolopoulou, M., Gordillo, R., Koliaki, C., Gancheva, S., Jelenik, T., De Filippo, E., Herder, C., Markgraf, D., Jankowiak, F., Esposito, I., et al. (2018) · Diabetes Care
Liver Disease Diagnosis and TreatmentSphingolipid Metabolism and Signaling
Cited by 284
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free